compound 11a was tested in an expanded tumor panel and was shown to be active against b16 melanocarcinoma , cd8f1 mammary , l1210 lymphoid leukemia , colon 38 , and mx-1 human tumor breast xenograft systems .
C0006141
mammary
C1458155
tumor breast